Expression of aldehyde dehydrogenase family 1 member A1 and high mobility group box 1 in oropharyngeal squamous cell carcinoma in association with survival time.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27900016)

Published in Oncol Lett on September 07, 2016

Authors

Xu Qian1, Annekatrin Coordes2, Andreas M Kaufmann3, Andreas E Albers2

Author Affiliations

1: Department of Otolaryngology, Head and Neck Surgery, Charité - Medical University of Berlin, Benjamin Franklin Campus, D-12200 Berlin, Germany; School of Basic Medical Science, Zhejiang Provincial Key Laboratory of Medical Genetics, Wenzhou Medical University, Wenzhou, Zhejiang 325035, P.R. China.
2: Department of Otolaryngology, Head and Neck Surgery, Charité - Medical University of Berlin, Benjamin Franklin Campus, D-12200 Berlin, Germany.
3: Clinic for Gynecology, Charité - Medical University of Berlin, Benjamin Franklin Campus, D-12200 Berlin, Germany.

Articles cited by this

Global cancer statistics. CA Cancer J Clin (2011) 185.92

Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22

Cancer statistics, 2008. CA Cancer J Clin (2008) 86.74

Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med (2010) 22.74

The molecular biology of head and neck cancer. Nat Rev Cancer (2010) 9.84

HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol (2010) 5.65

Structural features of the HMG chromosomal proteins and their genes. Biochim Biophys Acta (1990) 3.55

Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer (2006) 3.38

Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery (1999) 2.44

Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma. PLoS One (2011) 1.87

HMGB1 in health and disease. Mol Aspects Med (2014) 1.67

HMGB1 is secreted by immunostimulated enterocytes and contributes to cytomix-induced hyperpermeability of Caco-2 monolayers. Am J Physiol Cell Physiol (2005) 1.51

The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics. Oncogene (2013) 1.43

TLR4-mediated skin carcinogenesis is dependent on immune and radioresistant cells. EMBO J (2010) 1.37

Growth suppression and radiosensitivity increase by HMGB1 in breast cancer. Acta Pharmacol Sin (2007) 1.15

Elevated expression of HMGB1 in squamous-cell carcinoma of the head and neck and its clinical significance. Eur J Cancer (2010) 1.09

Frameshift mutations at coding mononucleotide repeats of the hRAD50 gene in gastrointestinal carcinomas with microsatellite instability. Cancer Res (2001) 1.07

Multidisciplinary approaches in the management of advanced head and neck tumors: state of the art. Curr Opin Oncol (2004) 1.00

Prognostic biomarkers of survival in oropharyngeal squamous cell carcinoma: systematic review and meta-analysis. Head Neck (2012) 1.00

High-mobility group box-1 and its role in angiogenesis. J Leukoc Biol (2014) 0.99

Contribution of human papilloma virus to the incidence of squamous cell carcinoma of the head and neck in a European population with high smoking prevalence. Eur J Cancer (2015) 0.95

Stem cells in squamous head and neck cancer. Crit Rev Oncol Hematol (2011) 0.94

HMGB1 mediates hyperglycaemia-induced cardiomyocyte apoptosis via ERK/Ets-1 signalling pathway. J Cell Mol Med (2014) 0.94

HMGB1 is overexpressed in tumor cells and promotes activity of regulatory T cells in patients with head and neck cancer. Oral Oncol (2012) 0.92

Platelets promote tumour metastasis via interaction between TLR4 and tumour cell-released high-mobility group box1 protein. Nat Commun (2014) 0.91

Susceptibility to cytotoxic T cell lysis of cancer stem cells derived from cervical and head and neck tumor cell lines. J Cancer Res Clin Oncol (2012) 0.91

The prognostic role of the cancer stem cell marker aldehyde dehydrogenase 1 in head and neck squamous cell carcinomas: a meta-analysis. Oral Oncol (2014) 0.91

High mobility group Box-1 inhibits cancer cell motility and metastasis by suppressing activation of transcription factor CREB and nWASP expression. Oncotarget (2014) 0.90

Clinical value of serum HMGB1 in diagnosis and prognosis of laryngeal squamous cell carcinoma. Med Oncol (2014) 0.88

Biology and immunology of cancer stem(-like) cells in head and neck cancer. Crit Rev Oncol Hematol (2015) 0.88

Prognostic significance of ALDH1A1-positive cancer stem cells in patients with locally advanced, metastasized head and neck squamous cell carcinoma. J Cancer Res Clin Oncol (2014) 0.86

High-Mobility Group Box 1 Promotes Hepatocellular Carcinoma Progression through miR-21-Mediated Matrix Metalloproteinase Activity. Cancer Res (2015) 0.84

Interaction effect between the receptor for advanced glycation end products (RAGE) and high-mobility group box-1 (HMGB-1) for the migration of a squamous cell carcinoma cell line. Tumori (2011) 0.83

HMGB1 promotes lymphangiogenesis of human lymphatic endothelial cells in vitro. Med Oncol (2010) 0.81

ALDH1-positive cancer stem-like cells are enriched in nodal metastases of oropharyngeal squamous cell carcinoma independent of HPV status. Oncol Rep (2013) 0.81

miR-21 increases the programmed cell death 4 gene-regulated cell proliferation in head and neck squamous carcinoma cell lines. Oncol Rep (2014) 0.80

Does HMGB1 predict occult neck lymph node metastasis in early tongue carcinoma? A case-control study of 26 patients. J Laryngol Otol (2014) 0.78